June 27, 2025 Weight Loss Drugs, Heavier Implications New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care. Conexiant
June 25, 2025 Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy The ASCO Post
June 25, 2025 Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy The ASCO Post
June 16, 2025 Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy The ASCO Post
June 17, 2025 Early-Phase Trial Shows Activity and Safety of Zongertinib in Previously Treated HER2-Mutant NSCLC The ASCO Post
June 16, 2025 AACR 2025: Zoldonrasib May Elicit Objective Responses in Patients With KRAS G12D–Mutated NSCLC The ASCO Post
June 16, 2025 AACR 2025: Oral HER2-Targeted Therapy for Advanced HER2-Mutated Lung Cancer The ASCO Post
June 17, 2025 Proposed Budget Cuts to Medicaid May Result in More Than 16,500 Medically Preventable Deaths Annually The ASCO Post